May 24, 2006|
Sugar: Macro Trends-II
In an earlier article, we gave an insight into the production and consumption aspects of the sugar industry. In this article, we take a look at some other aspects.
Sugarcane occupies about 2.7% of the total cultivated area and it is one of the most important cash crops in the country. From a level of 154 million tonnes (MT) in 1981, the cane production increased to 270 MT in 2005. Sugar cane is not only used for producing sugar but is also an input for traditional sweeteners like Gur and Khandsari. Almost 35% of cane production in India is utilised by the Gur manufacturers (see table below).
Sugarcane Utilization (in %) for different purposes
| Gur and Khandsari: Competitors |
Source : ISMA
||Gur and khandsari
||Seed, feed and chewing
The government has been following a dual pricing policy for sugar under which, a fixed percentage of the total production is to be necessarily sold by the sugar mills to the government at a pre-determined price. This is referred to as 'levy sugar'. The sugar so collected is distributed to consumers through Fair Price Shops under the Public Distribution System.
| Sugar pricing and distribution
The balance sugar, referred to as 'free sale sugar', can be sold in the open market. Free sale sugar is also regulated to some extent, by way of a release mechanism, whereby the government determines the quantum of sugar that can be sold every month. This helps the government maintain stability in sugar prices, by regulating the supply of sugar based on the underlying demand. In the 1990s, the ratio of free sugar to levy sugar was 60:40. However, since then, the levy imposed has reduced from 40% to 10% (90:10 ratio of free and levy sugar) effective March 2002.
Sugarcane cost accounts for 60% to 70% of the cost of production of sugar. The determination of price for sugarcane is, therefore, a matter of critical importance both for the sugar industry and the cane growers. The central government, before the onset of crushing season, declares the Statutory Minimum Price (SMP). It is linked to the base recovery rate of 8.5% with a premium for higher recovery. This mechanism has hurt the profitability of the sugar manufactures as the minimum price paid for the cane is increased every year irrespective of the sugar prices. SMP of sugarcane has increased at a compounded rate of 5.8% during the period 2001 to 2005, while the average sugar prices have increased at a lesser rate of 4.5% per annum.
| Cane prices Vs sugar prices |
The sugar industry is closely linked to the sugar price cycle. Higher cane and sugar production results in a decline in realisations for companies. Higher sugarcane and sugar production results in a fall in sugar prices and non-payment of dues to farmers. This compels the farmers to switch to other crops, thereby causing a shortage of sugarcane. This consequently leads to an increase in sugarcane prices. Taking into account the prevalent higher prices for cane, farmers then switch back to sugarcane. Due to this cyclical nature, sugar manufacturers are vulnerable to industry oscillations. However, sugar by-products like molasses (ethanol, ENA and rectified spirit) and bagasse aid the sugar producers in diversifying risks and lending stability to their revenues.
Basis: 1 MT of Cane at Recovery of 10% (Revenue in Rs)
| By-products - Additional revenue |
The sugar industry in India is supply-deficient. The industry will again face production shortfalls in the year 2006, with inventory filling the gap for the third year in a row. Deficit inventory coupled with rising demand of sugar and ethanol has changed the fortunes of Indian sugar companies. These companies are gradually transforming themselves from being conventional sugar mills into multi-product businesses by realising the potential of value added revenue streams from ethanol manufacturing and power co-generation. We believe that the industry would be positively impacted by both the structural and operational changes in the country.
|Co product revenue
More Views on News
Jun 20, 2017
While GSK consumer reported muted revenue growth, volumes are seen to be recovering.
Feb 8, 2017
ITC Ltd has announced third quarter results of the financial year 2016-2017 (3QFY17). The company has reported 4.7% YoY and 5.7% YoY growth in revenues and net profits respectively. Here is our analysis of the results.
Dec 7, 2016
ITC has announced second quarter results of the financial year 2016-2017 (2QFY17). The company has reported 8% YoY and 10.5% YoY growth in revenues and net profits respectively.
Jun 8, 2016
ITC declared results for the quarter and year ended March 2016. During the year, the company's net revenues and profits rise by 1% YoY and 3% YoY respectively.
Jun 1, 2016
GSK Consumer Healthcare announced its results for the quarter and year ended March 2016. During the quarter, sales and profit came in lower by 9% YoY and 8% YoY respectively.
More Views on News
Aug 7, 2017
The data tells us quite a different story from the one the government is trying to project.
Aug 4, 2017
The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.
Aug 8, 2017
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 7, 2017
Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: firstname.lastname@example.org. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407